Metagenomi Announces Participation in March Investor Conferences
EMERYVILLE, Calif.--(BUSINESS WIRE)--Metagenomi, a genetic medicines company with a versatile portfolio of next-generation gene editing tools, today announced that it will participate in two upcoming investor conferences. TD Cowen's 43rd Annual Health Care Conference In-Person March 7, 2023 Participants: Brian C. Thomas, PhD, CEO and Founder, Metagenomi; Jian Irish, PhD,...
